Stay updated on Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:53:46.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:42:23.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:57:31.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    - Removed the topic tags 'Prostate cancer' and the related topic 'MedlinePlus Genetics' from the study's metadata.
    Difference
    0.2%
    Check dated 2026-03-04T12:32:40.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added related topics: Prostate cancer and MedlinePlus Genetics appear as related topics on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T06:49:42.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The notice about government funding lapse and Revision: v3.4.1 were removed.
    Difference
    0.5%
    Check dated 2026-02-11T04:42:54.000Z thumbnail image

Stay in the know with updates to Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.